menu

With initial immuno-therapeutics focus, empowered by its platform technology for low-dose, target- and cell-specific delivery of oligo drugs, NapaJen aims to positively impact the major challenge of side effects and toxicity in the pharmaceutical industry, by creating safer and more efficacious treatments for unmet medical needs.

True Precision Medicine Meets Precision Delivery

By loading different oligo drugs onto its cell-specific drug delivery platform, NapaJen has made both
"precision-targeted immunosuppressive treatment" as well as "controlled immuno-stimulation" possible in preclinical models.

NapaJen Pharma, Inc.

533 Airport Blvd.,#527, Burlingame,
CA 94010 USA

Tel: 650-685-2429
FAX: 650-401-2221
email: info@napajen.com

Napa Jenomics Co., Ltd

URAC 1204, 2-24-16 Nakacho, Koganei, Tokyo 184-0012 Japan

Tel: 042-388-7381
FAX: 042-388-7757
email: info@napajen.com